Association of Genetic Variants in the TMCO1 Gene with Clinical Parameters Related to Glaucoma and Characterization of the Protein in the Eye

Total Page:16

File Type:pdf, Size:1020Kb

Association of Genetic Variants in the TMCO1 Gene with Clinical Parameters Related to Glaucoma and Characterization of the Protein in the Eye Glaucoma Association of Genetic Variants in the TMCO1 Gene with Clinical Parameters Related to Glaucoma and Characterization of the Protein in the Eye Shiwani Sharma,1,9 Kathryn P. Burdon,1,9 Glyn Chidlow,2 Sonja Klebe,1,3 April Crawford,1 David P. Dimasi,1 Alpana Dave,1 Sarah Martin,1 Shahrbanou Javadiyan,1 John P. M. Wood,2 Robert Casson,2 Patrick Danoy,4 Kim Griggs,3 Alex W. Hewitt,5 John Landers,1 Paul Mitchell,6 David A. Mackey,5,7,8 and Jamie E. Craig1 PURPOSE. Glaucoma is the leading cause of irreversible RESULTS. The data suggest that individuals homozygous for the blindness worldwide. Primary open angle glaucoma (POAG) rs4656461 risk allele (GG) are 4 to 5 years younger at diagnosis is the most common subtype. We recently reported association than noncarriers of this allele. Our data demonstrate expres- of genetic variants at chromosomal loci, 1q24 and 9p21, with sion of the TMCO1 protein in most tissues in the human eye, POAG. In this study, we determined association of the most including the trabecular meshwork and retina. However, the subcellular localization differs from that reported in other significantly associated single nucleotide polymorphism (SNP) studies. We demonstrate that the endogenous protein localizes rs4656461, at 1q24 near the TMCO1 gene, with the clinical to the cytoplasm and nucleus in vivo and ex vivo. In the parameters related to glaucoma risk and diagnosis, and nucleus, the protein localizes to the nucleoli. determined ocular expression and subcellular localization of the human TMCO1 protein to understand the mechanism of its CONCLUSIONS. This study shows a relationship between genetic variation in and around TMCO1 with age at diagnosis of POAG involvement in POAG. and provides clues to the potential cellular function/s of this METHODS. Association of SNP rs4656461 with five clinical gene. (Invest Ophthalmol Vis Sci. 2012;53:4917–4925) DOI: parameters was assessed in 1420 POAG cases using linear 10.1167/iovs.11-9047 regression. The TMCO1 gene was screened for mutations in 95 cases with a strong family history and advanced disease. Ocular laucoma refers to a group of neurodegenerative ocular expression and subcellular localization of the TMCO1 protein Gdiseases united by a clinically characteristic optic neurop- were determined by immunolabeling and as GFP-fusion. athy. Open-angle glaucoma (OAG) is common, with a prevalence of approximately 3% in people older than 50 years.1 The disease has long been known to have a genetic From the Departments of 1Ophthalmology and 3Pathology, component. First-degree relatives of affected patients exhibit a Flinders University, Flinders Medical Centre, Adelaide, Australia; 9-fold increased relative risk of developing primary OAG 2South Australian Institute of Ophthalmology, Hanson Institute & (POAG) compared with the general population.2 The Glauco- 4 The University of Adelaide, Adelaide, Australia; The University of ma Inheritance Study in Tasmania (GIST) revealed that a Queensland Diamantina Institute, Princess Alexandra Hospital, 5 positive family history is found in approximately 60% of cases Brisbane, Australia; Centre for Eye Research Australia, University 3 of Melbourne, Royal Victorian Eye and Ear Hospital, Melbourne, of POAG when family members are examined, and the disease Australia; 6Centre for Vision Research, Department of Ophthalmol- is more severe in people with a family history of glaucoma, ogy and Westmead Millennium Institute, University of Sydney, compared with those with ‘‘sporadic’’ glaucoma.4 Mutations in Westmead, Australia; 7Lions Eye Institute, University of Western the myocilin gene (MYOC) are the most common reported Australia, Centre for Ophthalmology and Visual Science, Perth, genetic cause of POAG and account for approximately 3% to Australia; and 8Discipline of Medicine, University of Tasmania, 5% of cases.5 Mutations in optineurin (OPTN) and WDR36 Hobart, Australia. genes have also been implicated.5 Recent genome-wide 9 These authors contributed equally to the work presented here association studies have identified common variants at several and should therefore be regarded as equivalent authors. new genetic loci are associated with POAG, including CAV1 Supported by National Health and Medical Research Council and CAV2 on chromosome 7q31; CDKN2B-AS1, CDKN2A, and (NHMRC) of Australia, Glaucoma Australia, and Ophthalmic Re- 6,7 search Institute of Australia. Support was also provided by the CDKN2B on 9p21; and TMCO1 on 1q24. The mechanism of NHMRC Career Development Award (KPB) and the Practitioner disease association is not yet clear for any of these genetic Fellowship (JEC). associations and very little is known about the normal function Submitted for publication November 9, 2011; revised March 27 of TMCO1 and its role in the eye. and May 27, 2012; accepted June 12, 2012. The TMCO1 gene encodes the Transmembrane and coiled- Disclosure: S. Sharma,None;K.P. Burdon,None;G. coil domains-1 protein which belongs to the DUF841 Chidlow,None;S. Klebe,None;A. Crawford,None;D.P. Dimasi, superfamily of unknown function.8 Thegeneislocated None; A. Dave,None;S. Martin,None;S. Javadiyan,None;J.P.M. approximately 6 Mb upstream of the known POAG gene Wood,None;R. Casson,None;P. Danoy,None;K. Griggs,None; MYOC on chromosome 1. The protein sequence is highly A.W. Hewitt,None;J. Landers,None;P. Mitchell,None;D.A. 9 Mackey,None;J.E. Craig,None conserved across mammalian species. The gene is expressed 9 Corresponding author: Shiwani Sharma, Department of Oph- in a variety of human adult and fetal tissues at varying levels, thalmology, Flinders University, GPO Box 2100, Adelaide 5001, including ocular tissues.6 Immunohistochemistry revealed Australia; shiwani.sharma@flinders.edu.au. cytoplasmic labeling in the rat retinal ganglion cell layer.6 Investigative Ophthalmology & Visual Science, July 2012, Vol. 53, No. 8 Copyright 2012 The Association for Research in Vision and Ophthalmology, Inc. 4917 Downloaded From: http://iovs.arvojournals.org/pdfaccess.ashx?url=/data/journals/iovs/933262/ on 02/09/2017 4918 Sharma et al. IOVS, July 2012, Vol. 53, No. 8 The green fluorescent protein (GFP)-fusion of TMCO1 has provided written informed consent. Approval was obtained from the been reported to localize to endoplasmic reticulum and Golgi Human Research Ethics Committees (HRECs) of Southern Adelaide apparatus in COS7 cells,10 and to the mitochondria in porcine Health Service/Flinders University, University of Tasmania, and The PK-15 cells.8 These reports suggest that the subcellular Royal Victorian Eye and Ear Hospital. All participants were screened for localization of the protein may differ depending on cell type. mutations in the MYOC gene by direct sequencing of exon 3 on an ABI A homozygous frame-shift mutation in the TMCO1 gene has PRISM 3100 Genetic Analyzer (Applied Biosystems, Foster City, CA) been shown to cause a rare recessive syndrome in the Amish, with BigDye Terminators (Applied Biosystems) according to standard consisting of craniofacial dysmorphism, skeletal anomalies, and protocols. Primer sequences are available on request. mental retardation, now known as ‘‘TMCO1 defect syn- drome.’’9 There are no reports of glaucoma in this family. Genotyping and Association Analysis Our recent study failed to find any coding mutations in POAG patients carrying two risk haplotypes at the TMCO1 locus, Genotyping of the rs4656461 SNP was conducted as previously indicating that coding mutations in TMCO1 are unlikely to reported.6 Briefly, samples originally included in the discovery phase of account for the association observed with POAG.6 the genome-wide association scan were genotyped on Omni1 SNP The most associated single nucleotide polymorphism (SNP) arrays (Illumina Inc., San Diego, CA), whereas those included in the at the 1q24 locus (rs4656461) is just 30 to TMCO1 and the replication phase were typed with iPlex Gold chemistry on an Autoflex second ranked SNP rs7518099 is within intron 2 of this gene and Mass Spectrometer (Sequenom Inc., San Diego, CA). Each clinical trait is in almost complete linkage disequilibrium with rs4656461. In was assessed for association with SNP rs4656461 (the glaucoma- addition, the highest ranked imputed SNP, rs7524755 is within associated SNP tagging the at-risk haplotype as reported previously6) the 30 UTR of TMCO1.6 All the associated SNPs are within the using linear regression under a dominant genetic model. This model same linkage disequilibrium block as TMCO1 with no other was chosen to maintain statistical power because this SNP is relatively transcripts in the block. The common haplotype across the rare (minor allele frequency approximately 12%) and only 24 gene, which is efficiently tagged by the most associated SNP, homozygous patients were observed in our cohort. SNP genotypes increases the risk of POAG. This association was discovered in a were coded as carriers of the POAG risk allele (GA or GG genotype) cohort of POAG patients with severe blinding disease, and noncarriers (AA genotype), and analyzed in the model as a replicated in a second similar cohort and another cohort with categorical variable. The assumptions of linear regression were met. A less-severe glaucoma.6 From these data, however, it is as yet P value of 0.01 was required to account for the multiple testing of five unclear whether TMCO1 genetic variation can be used to traits (highest recorded IOP, age at diagnosis, mean deviation, cup:disc pinpoint a distinct subtype of POAG or if TMCO1 mutations ratio, and central corneal thickness). Significantly associated traits were might contribute to some cases of familial OAG. then assessed under multivariate analysis including each of the other In the present study, we further investigated the TMCO1 traits as well as sex in the model. Analyses were conducted including gene for association with clinical traits relevant to glaucoma and excluding patients with known MYOC mutations. All analyses were risk and diagnosis, and screened for mutations in patients with conducted using IBM-SPSS Statistics V19 (IBM Corp., Armonk, NY). a strong family history of POAG.
Recommended publications
  • Human Prostate Cancer Cell Apoptosis
    HUMAN PROSTATE CANCER CELL APOPTOSIS INDUCED BY INTERFERON-γ AND DOUBLE-STRANDED RNA AND STUDIES ON THE BIOLOGICAL ROLES OF TRANSMEMBRANE AND COILED-COIL DOMAINS 1 HAIYAN TAN Bachelor of Science in Medicine Norman Bethune University of Medical Sciences, China July, 1995 Submitted in partial fulfillment of the requirements for the degree DOCTOR OF PHILOSOPHY IN CLINICAL AND BIOANALYTICAL CHEMISTRY at the CLEVEALND STATE UNIVERSTIY August, 2010 This dissertation has been approved for the Department of Chemistry and the College of Graduate Studies by Dissertation Committee Chairperson, Dr. Aimin Zhou Department & Date Dr. David Anderson Department & Date Dr. Xue-long Sun Department & Date Dr. Crystal M Weyman Department & Date Dr. Sihe Wang Department & Date ACKNOWLEDGEMENTS First and foremost, I want to heartily thank my advisor, Dr. Aimin Zhou, for his exceptional mentorship and constant support throughout my Ph.D. work. He was always available to listen to and discuss my ideas and questions, and showed me different ways to research problems. Most importantly, he taught me the need to be persistent to accomplish any goal, and his optimistic attitude toward his career and life has deeply affected me. I would like to express my special appreciation to my advisory committee, Dr. David Anderson, Dr. Crystal M Weyman, Dr. Sihe Wang, and Dr. Xue-long Sun, for their advice, encouragement, and support. Dr. Anderson provided me with a lot of encouragement and support. His instruction for my first job interview in the United States really touched me. Dr. Weyman is a model of a successful woman scientist and her instruction is always helpful.
    [Show full text]
  • Homozygous Frameshift Mutation in TMCO1 Causes a Syndrome with Craniofacial Dysmorphism, Skeletal Anomalies, and Mental Retardation
    Homozygous frameshift mutation in TMCO1 causes a syndrome with craniofacial dysmorphism, skeletal anomalies, and mental retardation Baozhong Xina, Erik G. Puffenbergerb,c, Susan Turbena, Haiyan Tand, Aimin Zhoud, and Heng Wanga,e,f,1 aDDC Clinic for Special Needs Children, Middlefield, OH 44062; bThe Clinic for Special Children, Strasburg, PA 17579; cDepartment of Biology, Franklin and Marshall College, Lancaster, PA 17603; dDepartment of Chemistry, Cleveland State University, Cleveland, OH 44115; eDepartment of Pediatrics, Rainbow Babies and Children’s Hospital, Cleveland, OH 44106; and fDepartment of Molecular Cardiology, Cleveland Clinic, Cleveland, OH 44195 Edited by Albert de la Chapelle, Ohio State University Comprehensive Cancer Center, Columbus, OH, and approved November 18, 2009 (received for review July 27, 2009) We identified an autosomal recessive condition in 11 individuals Results in the Old Order Amish of northeastern Ohio. The syndrome was Clinical Phenotype. TMCO1 defect syndrome was diagnosed in 11 characterized by distinctive craniofacial dysmorphism, skeletal individuals (6 males, 5 females) ranging in age from 3 to 39 years. anomalies, and mental retardation. The typical craniofacial dys- All 11 patients demonstrated Old Order Amish ancestry, and morphism included brachycephaly, highly arched bushy eye- genealogical analyses revealed multiple lines of common descent brows, synophrys, long eyelashes, low-set ears, microdontism of between all parents of affected children (Fig. 1). The phenotype primary teeth, and generalized gingival hyperplasia, whereas was not observed in the parents or 23 unaffected siblings. Sprengel deformity of scapula, fusion of spine, rib abnormities, A history of first trimester spontaneous abortions was reported pectus excavatum, and pes planus represented skeletal anomalies.
    [Show full text]
  • A Systems-Genetics Analyses of Complex Phenotypes
    A systems-genetics analyses of complex phenotypes A thesis submitted to the University of Manchester for the degree of Doctor of Philosophy in the Faculty of Life Sciences 2015 David Ashbrook Table of contents Table of contents Table of contents ............................................................................................... 1 Tables and figures ........................................................................................... 10 General abstract ............................................................................................... 14 Declaration ....................................................................................................... 15 Copyright statement ........................................................................................ 15 Acknowledgements.......................................................................................... 16 Chapter 1: General introduction ...................................................................... 17 1.1 Overview................................................................................................... 18 1.2 Linkage, association and gene annotations .............................................. 20 1.3 ‘Big data’ and ‘omics’ ................................................................................ 22 1.4 Systems-genetics ..................................................................................... 24 1.5 Recombinant inbred (RI) lines and the BXD .............................................. 25 Figure 1.1:
    [Show full text]
  • Full-Text.Pdf
    Systematic Evaluation of Genes and Genetic Variants Associated with Type 1 Diabetes Susceptibility This information is current as Ramesh Ram, Munish Mehta, Quang T. Nguyen, Irma of September 23, 2021. Larma, Bernhard O. Boehm, Flemming Pociot, Patrick Concannon and Grant Morahan J Immunol 2016; 196:3043-3053; Prepublished online 24 February 2016; doi: 10.4049/jimmunol.1502056 Downloaded from http://www.jimmunol.org/content/196/7/3043 Supplementary http://www.jimmunol.org/content/suppl/2016/02/19/jimmunol.150205 Material 6.DCSupplemental http://www.jimmunol.org/ References This article cites 44 articles, 5 of which you can access for free at: http://www.jimmunol.org/content/196/7/3043.full#ref-list-1 Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision by guest on September 23, 2021 • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2016 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Systematic Evaluation of Genes and Genetic Variants Associated with Type 1 Diabetes Susceptibility Ramesh Ram,*,† Munish Mehta,*,† Quang T.
    [Show full text]
  • The Genetic and Endoplasmic Reticulum-Mediated Molecular Mechanisms of Primary Open-Angle Glaucoma
    International Journal of Molecular Sciences Review The Genetic and Endoplasmic Reticulum-Mediated Molecular Mechanisms of Primary Open-Angle Glaucoma 1, 1, 2 3 Wioletta Rozp˛edek-Kami´nska y , Radosław Wojtczak y, Jacek P. Szaflik , Jerzy Szaflik and Ireneusz Majsterek 1,* 1 Department of Clinical Chemistry and Biochemistry, Medical University of Lodz, 90-419 Lodz, Poland; [email protected] (W.R.-K.); [email protected] (R.W.) 2 Department of Ophthalmology, SPKSO Ophthalmic Hospital, Medical University of Warsaw, 03-709 Warsaw, Poland; jacek@szaflik.pl 3 Laser Eye Microsurgery Center, Clinic of Jerzy Szaflik, 00-215 Warsaw, Poland; jerzy@szaflik.pl * Correspondence: [email protected]; Tel.: +48-42-272-53-00 These authors contributed equally to this work. y Received: 27 April 2020; Accepted: 9 June 2020; Published: 11 June 2020 Abstract: Glaucoma is a heterogenous, chronic, progressive group of eye diseases, which results in irreversible loss of vision. There are several types of glaucoma, whereas the primary open-angle glaucoma (POAG) constitutes the most common type of glaucoma, accounting for three-quarters of all glaucoma cases. The pathological mechanisms leading to POAG pathogenesis are multifactorial and still poorly understood, but it is commonly known that significantly elevated intraocular pressure (IOP) plays a crucial role in POAG pathogenesis. Besides, genetic predisposition and aggregation of abrogated proteins within the endoplasmic reticulum (ER) lumen and subsequent activation of the protein kinase RNA-like endoplasmic reticulum kinase (PERK)-dependent unfolded protein response (UPR) signaling pathway may also constitute important factors for POAG pathogenesis at the molecular level.
    [Show full text]
  • (TMCO1) Is Not a Risk Factor for Primary Open Angle Glaucoma in a Saudi Cohort Altaf A
    Kondkar et al. Journal of Negative Results in BioMedicine (2016) 15:17 DOI 10.1186/s12952-016-0060-1 RESEARCH Open Access Polymorphism rs7555523 in transmembrane and coiled-coil domain 1 (TMCO1) is not a risk factor for primary open angle glaucoma in a Saudi cohort Altaf A. Kondkar1,2, Ahmed Mousa1,2, Taif A. Azad1,2, Tahira Sultan1,2, Abdullah Alawad3, Saleh Altuwaijri4,5, Saleh A. Al-Obeidan1,2 and Khaled K. Abu-Amero1,2,6* Abstract Background: We investigated whether polymorphism rs7555523 (A > C) in human transmembrane and coiled-coil domain 1 (TMCO1) gene is a risk factor for primary open angle glaucoma (POAG) in a Saudi cohort. Methods: A cohort of 87 unrelated POAG cases and 94 control subjects from Saudi Arabia were genotyped using Taq-Man® assay. The association of genotypes with POAG and other glaucoma specific clinical indices was investigated. Results: The genotype and allele frequency of polymorphism rs7555523 at TMCO1 did not show any statistically significant association with POAG as compared to controls. The minor allele frequency was 0.103 in cases and 0.085 in controls. Except for awareness of glaucoma (p = 0.036), no significant association of genotypes were seen with glaucoma specific clinical indices such as intraocular pressure (IOP), cup/disc ratio and number of anti-glaucoma medications used. Binary logistic regression analysis (adjusted for age and gender) showed that age was a significant indicator for the development of glaucoma in this group (adjusted odds ratio = 1.2; 95 % confidence interval = 1.078–1.157; p < 0.001). Conclusion: Our study was unable to replicate the findings of previously reported association for polymorphism rs7555523 in TMCO1 with POAG and related clinical indices such as IOP and cup/disc ratio indicating that this variant is not a risk factor for POAG in the Saudi cohort.
    [Show full text]
  • Genomic Locus Modulating IOP in the BXD RI Mouse
    Genomic Locus Modulating IOP in the BXD RI Mouse Strains Rebecca King, Emory University Ying Li, Emory University Jiaxing Wang, Emory University Felix Struebing, Emory University Eldon Geisert Jr, Emory University Journal Title: G3 Volume: Volume 8, Number 5 Publisher: Genetics Society of America: G3 | 2018-05-01, Pages 1571-1578 Type of Work: Article | Final Publisher PDF Publisher DOI: 10.1534/g3.118.200190 Permanent URL: https://pid.emory.edu/ark:/25593/s9q6d Final published version: http://dx.doi.org/10.1534/g3.118.200190 Copyright information: © 2018 King et al. This is an Open Access work distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/). Accessed September 26, 2021 5:47 PM EDT INVESTIGATION Genomic Locus Modulating IOP in the BXD RI Mouse Strains Rebecca King,* Ying Li,* Jiaxing Wang,*,† Felix L. Struebing,* and Eldon E. Geisert*,1 *Department of Ophthalmology, Emory University, Atlanta, Georgia 30322 and †Department of Ophthalmology, Tianjin Medical University General Hospital, Tianjin, China ORCID IDs: 0000-0003-0874-0102 (R.K.); 0000-0002-9615-4914 (Y.L.); 0000-0001-8958-6893 (J.W.); 0000-0002-9436-6294 (F.L.S.); 0000-0003-0787-4416 (E.E.G.) ABSTRACT Intraocular pressure (IOP) is the primary risk factor for developing glaucoma, yet little is known KEYWORDS about the contribution of genomic background to IOP regulation. The present study leverages an array of BXD systems genetics tools to study genomic factors modulating normal IOP in the mouse. The BXD cadherin recombinant inbred (RI) strain set was used to identify genomic loci modulating IOP.
    [Show full text]
  • Intracellular Calcium Dysregulation by the Alzheimer's Disease-Linked Protein Presenilin 2
    International Journal of Molecular Sciences Review Intracellular Calcium Dysregulation by the Alzheimer’s Disease-Linked Protein Presenilin 2 1,2, 1, 1,2,3 1,2, 1,2 Luisa Galla y, Nelly Redolfi y, Tullio Pozzan , Paola Pizzo * and Elisa Greotti 1 Department of Biomedical Sciences, University of Padua, 35131 Padua, Italy; [email protected] (L.G.); nelly.redolfi@unipd.it (N.R.); [email protected] (T.P.); [email protected] (E.G.) 2 Neuroscience Institute, National Research Council (CNR), 35131 Padua, Italy 3 Venetian Institute of Molecular Medicine (VIMM), 35131 Padua, Italy * Correspondence: [email protected] These authors contributed equally to this work. y Received: 17 December 2019; Accepted: 21 January 2020; Published: 24 January 2020 Abstract: Alzheimer’s disease (AD) is the most common form of dementia. Even though most AD cases are sporadic, a small percentage is familial due to autosomal dominant mutations in amyloid precursor protein (APP), presenilin-1 (PSEN1), and presenilin-2 (PSEN2) genes. AD mutations contribute to the generation of toxic amyloid β (Aβ) peptides and the formation of cerebral plaques, leading to the formulation of the amyloid cascade hypothesis for AD pathogenesis. Many drugs have been developed to inhibit this pathway but all these approaches currently failed, raising the need to find additional pathogenic mechanisms. Alterations in cellular calcium (Ca2+) signaling have also been reported as causative of neurodegeneration. Interestingly, Aβ peptides, mutated presenilin-1 (PS1), and presenilin-2 (PS2) variously lead to modifications in Ca2+ homeostasis. In this contribution, we focus on PS2, summarizing how AD-linked PS2 mutants alter multiple Ca2+ pathways and the functional consequences of this Ca2+ dysregulation in AD pathogenesis.
    [Show full text]
  • Supplementary Table 1. Hypermethylated Loci in Estrogen-Pre-Exposed Stem/Progenitor-Derived Epithelial Cells
    Supplementary Table 1. Hypermethylated loci in estrogen-pre-exposed stem/progenitor-derived epithelial cells. Entrez Gene Probe genomic location* Control# Pre-exposed# Description Gene ID name chr5:134392762-134392807 5307 PITX1 -0.112183718 6.077605311 paired-like homeodomain transcription factor 1 chr12:006600331-006600378 171017 ZNF384 -0.450661784 6.034362758 zinc finger protein 384 57121 GPR92 G protein-coupled receptor 92 chr3:015115848-015115900 64145 ZFYVE20 -1.38491748 5.544950925 zinc finger, FYVE domain containing 20 chr7:156312210-156312270 -2.026450994 5.430611412 chr4:009794114-009794159 9948 WDR1 0.335617144 5.352264173 WD repeat domain 1 chr17:007280631-007280676 284114 TMEM102 -2.427266294 5.060047786 transmembrane protein 102 chr20:055274561-055274606 655 BMP7 0.764898513 5.023260524 bone morphogenetic protein 7 chr10:088461669-088461729 11155 LDB3 0 4.817869864 LIM domain binding 3 chr7:005314259-005314304 80028 FBXL18 0.921361233 4.779265347 F-box and leucine-rich repeat protein 18 chr9:130571259-130571313 59335 PRDM12 1.123111331 4.740306098 PR domain containing 12 chr2:054768043-054768088 6711 SPTBN1 -0.089623066 4.691756995 spectrin, beta, non-erythrocytic 1 chr10:070330822-070330882 79009 DDX50 -2.848748309 4.691491169 DEAD (Asp-Glu-Ala-Asp) box polypeptide 50 chr1:162469807-162469854 54499 TMCO1 1.495802762 4.655023656 transmembrane and coiled-coil domains 1 chr2:080442234-080442279 1496 CTNNA2 1.296310425 4.507269831 catenin (cadherin-associated protein), alpha 2 347730 LRRTM1 leucine rich repeat transmembrane
    [Show full text]
  • Genomic Locus Modulating IOP in the BXD RI Mouse Strains
    INVESTIGATION Genomic Locus Modulating IOP in the BXD RI Mouse Strains Rebecca King,* Ying Li,* Jiaxing Wang,*,† Felix L. Struebing,* and Eldon E. Geisert*,1 *Department of Ophthalmology, Emory University, Atlanta, Georgia 30322 and †Department of Ophthalmology, Tianjin Medical University General Hospital, Tianjin, China ORCID IDs: 0000-0003-0874-0102 (R.K.); 0000-0002-9615-4914 (Y.L.); 0000-0001-8958-6893 (J.W.); 0000-0002-9436-6294 (F.L.S.); 0000-0003-0787-4416 (E.E.G.) ABSTRACT Intraocular pressure (IOP) is the primary risk factor for developing glaucoma, yet little is known KEYWORDS about the contribution of genomic background to IOP regulation. The present study leverages an array of BXD systems genetics tools to study genomic factors modulating normal IOP in the mouse. The BXD cadherin recombinant inbred (RI) strain set was used to identify genomic loci modulating IOP. We measured the eye IOP in a total of 506 eyes from 38 different strains. Strain averages were subjected to conventional glaucoma quantitative trait analysis by means of composite interval mapping. Candidate genes were defined, and intraocular immunohistochemistry and quantitative PCR (qPCR) were used for validation. Of the 38 BXD strains pressure examined the mean IOP ranged from a low of 13.2mmHg to a high of 17.1mmHg. The means for each strain IOP were used to calculate a genome wide interval map. One significant quantitative trait locus (QTL) was found mouse on Chr.8 (96 to 103 Mb). Within this 7 Mb region only 4 annotated genes were found: Gm15679, Cdh8, quantitative trait Cdh11 and Gm8730. Only two genes (Cdh8 and Cdh11) were candidates for modulating IOP based on the mapping presence of non-synonymous SNPs.
    [Show full text]
  • Homozygous Frameshift Mutation in TMCO1 Causes a Syndrome with Craniofacial Dysmorphism, Skeletal Anomalies, and Mental Retardation
    Homozygous frameshift mutation in TMCO1 causes a syndrome with craniofacial dysmorphism, skeletal anomalies, and mental retardation Baozhong Xina, Erik G. Puffenbergerb,c, Susan Turbena, Haiyan Tand, Aimin Zhoud, and Heng Wanga,e,f,1 aDDC Clinic for Special Needs Children, Middlefield, OH 44062; bThe Clinic for Special Children, Strasburg, PA 17579; cDepartment of Biology, Franklin and Marshall College, Lancaster, PA 17603; dDepartment of Chemistry, Cleveland State University, Cleveland, OH 44115; eDepartment of Pediatrics, Rainbow Babies and Children’s Hospital, Cleveland, OH 44106; and fDepartment of Molecular Cardiology, Cleveland Clinic, Cleveland, OH 44195 Edited by Albert de la Chapelle, Ohio State University Comprehensive Cancer Center, Columbus, OH, and approved November 18, 2009 (received for review July 27, 2009) We identified an autosomal recessive condition in 11 individuals Results in the Old Order Amish of northeastern Ohio. The syndrome was Clinical Phenotype. TMCO1 defect syndrome was diagnosed in 11 characterized by distinctive craniofacial dysmorphism, skeletal individuals (6 males, 5 females) ranging in age from 3 to 39 years. anomalies, and mental retardation. The typical craniofacial dys- All 11 patients demonstrated Old Order Amish ancestry, and morphism included brachycephaly, highly arched bushy eye- genealogical analyses revealed multiple lines of common descent brows, synophrys, long eyelashes, low-set ears, microdontism of between all parents of affected children (Fig. 1). The phenotype primary teeth, and generalized gingival hyperplasia, whereas was not observed in the parents or 23 unaffected siblings. Sprengel deformity of scapula, fusion of spine, rib abnormities, A history of first trimester spontaneous abortions was reported pectus excavatum, and pes planus represented skeletal anomalies.
    [Show full text]
  • Whole Exome Sequencing of a Large Family with Primary Open Angle Glaucoma
    bioRxiv preprint doi: https://doi.org/10.1101/2020.09.21.306191; this version posted September 23, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Whole Exome Sequencing of a large family with Primary Open Angle Glaucoma reveals its vast complexity. Mohd Hussain Shah1*, Manojkumar Kumaran2,5*, Mohideen Abdul Kader3, R. Ramakrishnan3, Subbiah. R. Krishnadas4, Bharanidharan Devarajan2@, and Periasamy Sundaresan1@ 1Department of Molecular Genetics, Aravind Medical Research Foundation, Dr.G.Venkataswamy Eye Research Institute, Madurai, Tamil Nadu, India 2Department of Bioinformatics, Aravind Medical Research Foundation, Dr.G.Venkataswamy Eye Research Institute, Madurai, Tamil Nadu, India 3Glaucoma Clinic, Aravind Eye Hospital, Tirunelveli, Tamil Nadu, India 4Glaucoma Clinic, Aravind Eye Hospital, Madurai, Tamil Nadu, India 5School of Chemical and Biotechnology, SASTRA (Deemed to be University), Thanjavur, Tamil Nadu, India *First two authors contributed equally to this work @Corresponding Authors. @ Corresponding Authors: Bharanidharan, Devarajan E-Mail: [email protected] Telephone: 91-452-253 0984 Extn.467 Periasamy, Sundaresan E-Mail: [email protected] Telephone: 91-452-253 0984 Extn.423 bioRxiv preprint doi: https://doi.org/10.1101/2020.09.21.306191; this version posted September 23, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Abstract Multiple studies have identified several pathogenic variants, majorly contribute to the pathogenesis of primary open-angle glaucoma (POAG). However, these genetic factors can only explain 5-6% of POAG. To identify pathogenic variants associated with POAG by using Whole Exome Sequencing (WES) data of an Egyptian origin of a large family with POAG settled in South India.
    [Show full text]